Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Revenue from product rentals and other services in APAC, as well as revenue from treatment services and other services in the United States, increased. Other selling, general and administrative expenses declined as a result of cost reductions. Financial income increased due to gains on the valuation of investment securities, foreign exchange gains and other factors.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | ¥1,027 million (YoY +2.7%) |
| Operating profit | ¥-17 million |
| Ordinary income | ¥576 million (profit before tax for the quarter) (YoY +33.1%) |
| Profit attributable to owners of the parent | ¥374 million (YoY +49.2%) |
| Net income per share | ¥1.77 |
| Equity ratio | End of the current fiscal period 80.7 / End of previous period 80.7 |
| Total assets | ¥49,737 million |
| Net assets | ¥40,083 million (total equity) |
| Cash flows from operating activities | ¥121 million |
| Cash flows from investing activities | ¥4,066 million |
| Cash flows from financing activities | ¥-58 million |
| Cash and cash equivalents at end of period | ¥13,117 million |
| Full-year earnings forecast | Net Sales Not disclosed / Operating profit Not disclosed / Ordinary income Not disclosed / Net income Not disclosed / Remarks No consolidated earnings forecasts have been disclosed |
| Annual Dividend Forecast | ¥0 → Not disclosed |
| Depreciation and amortization | ¥154 million |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed |
| Changes in the scope of consolidation | New Number of companies 0 companies / Company name Not disclosed / Excluded Number of companies 0 companies / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 215,145,809 |
| Treasury Shares at Period-End | 4,014,804 |
| Factors Behind Changes in Business Performance | Revenue from product rentals and other services in APAC, as well as revenue from treatment services and other services in the United States, increased. Other selling, general and administrative expenses declined as a result of cost reductions. Financial income increased due to gains on the valuation of investment securities, foreign exchange gains and other factors. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue from product rentals and other services in APAC, as well as revenue from treatment services and other services in the United States, increased. Other selling, general and administrative expenses declined as a result of cost reductions, while financial income increased due to gains on the valuation of investment securities, foreign exchange gains and other factors.